News | AseBio - Asociación Empresas Biotecnología

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine

bcn health newsletter en ingles

BCN HEALTH has participated in the "Global Thalassaemia Review 2021 Report" developed by the Thalassaemia International Federation

With the data obtained in the targeted literature, a cost-of-illness model has been developed to…

foto algenex

The EMA validates Algenex's CrisBio® technology platform, for the manufacture of vaccines

This European recommendation has validated the use of this technology to produce recombinant…

Dámaso Melero 2021

#InterviewBiospain2021 | The company born drinking a beer that ended up as the first to develop biosimilars in Spain

3P Biopharmaceuticals operates globally, with 19 active projects worldwide and has positioned…

imagen foto genesis biomed

A FECYT report concludes that the entire innovation incentive scheme needs to be redesigned

GENESIS Biomed has participated in the preparation of the THINK TANK report "Patenting and/or…

foto de medicina de precisión

Personalised medicine increases its activity by 40% in the last year and is becoming more decisive

Personalized medicine

Precision medicine and personalised medicine products or services have gone from representing 12%…

FOTO ORYZON

ORYZON presents safety and efficacy data of vafidemstat from the Phase II ESCAPE trial in severe CoVID-19 patients at ECCMID-2021

Vafidemstat was safe and well tolerated Confirmed anti-inflammatory activity of vafidemstat…

foto oyrzon

ORYZON receives approval to start EVOLUTION Phase IIb trial with vafidemstat in schizophrenia

Clinical Trial Application approved by Spanish Drug Agency Primary objectives: to assess the…

acorys equipment

Corify Care raises €2.35M to translate its cardiac mapping technology to the market

Healthcare · Personalized medicine · Financing

The investment round is led by Clave Capital, counting with investment from CDTI through its…

Ysios Capital anuncia la salida a bolsa en el NASDAQ de su compañía participada CVRx, Inc.

Ysios Capital’s portfolio company CVRx Inc. prices IPO on NASDAQ

This is a major achievement for Ysios as CVRx is its fifth portfolio company to be listed on NASDAQ…